Literature DB >> 26119883

Oxygen requirement as a screening tool for the detection of late pulmonary hypertension in extremely low birth weight infants.

Rohit Aswani1, Lisa Hayman1, Gina Nichols1, Angel A Luciano1, Ernest K Amankwah2, Jennifer L Leshko2, Gul H Dadlani1.   

Abstract

BACKGROUND: Many extremely low birth weight infants develop pulmonary hypertension late in their clinical course, and over 60% go undetected by early screening echocardiography. At present, no standardised screening protocol exists for detecting late pulmonary hypertension in extremely low birth weight infants. We assessed the utility of oxygen supplementation as a predictor of late pulmonary hypertension.
METHODS: A retrospective single-centre review of extremely low birth weight infants with no evidence of CHD and those surviving for >30 days was performed. The association between oxygen ⩾30% at day of life 30 and diagnosis of late pulmonary hypertension was estimated with an odds ratio and 95% confidence interval using logistic regression. Doppler echocardiography was used to diagnose pulmonary hypertension in the infants.
RESULTS: A total of 230 infants met the study criteria. The incidence of late pulmonary hypertension was 8.3% (19/230). Infants with late pulmonary hypertension were more likely to have a lower mean birth weight (667.1±144 versus 799.3±140 g, p=0.001) and more likely to be small for gestational age (47.4 versus 14.2%, p=0.004). Oxygen requirement ⩾30% at day of life 30 was associated with increased risk of late pulmonary hypertension (odds ratio=3.77, 95% confidence interval=1.42-10.00, p=0.008) in univariate analysis and after adjusting for birth weight (odds ratio=2.47, 95% confidence interval=0.89-6.84, p=0.08).
CONCLUSIONS: The need of oxygen supplementation ⩾30% at day of life 30 may be a good screening tool for detecting late pulmonary hypertension in extremely low birth weight infants.

Entities:  

Keywords:  Pulmonary hypertension; bronchopulmonary dysplasia; echocardiography; extremely low birth weight infants; oxygen requirement; screening test

Mesh:

Substances:

Year:  2015        PMID: 26119883     DOI: 10.1017/S1047951115000608

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  4 in total

Review 1.  Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

Authors:  G Al-Ghanem; P Shah; S Thomas; L Banfield; S El Helou; C Fusch; A Mukerji
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

2.  Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers.

Authors:  Michael G O'Connor; Divya Suthar; Kimberly Vera; James C Slaughter; Natalie L Maitre; Steven Steele; Amy Beller; Candice D Fike; Judy L Aschner; Paul E Moore; Eric D Austin
Journal:  Pediatr Pulmonol       Date:  2017-11-23

Review 3.  Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population.

Authors:  Michael Glenn O'Connor; David N Cornfield; Eric D Austin
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

4.  Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension.

Authors:  Joseph M Collaco; Gul H Dadlani; Melanie K Nies; Jenny Leshko; Allen D Everett; Sharon A McGrath-Morrow
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.